Govt lifts export curbs on diagnostic kits, reagents

Published On 2021-10-17 04:30 GMT | Update On 2021-11-17 11:42 GMT

New Delhi: With COVID-19 cases coming down in the country, the government on Friday removed export curbs on all diagnostic kits and reagents including instruments, which are used in detection of coronavirus infections.

India logged 16,862 new coronavirus infections, taking the total tally of COVID-19 cases to 3,40,37,592, while the active cases declined to 2,03,678, the lowest in 216 days, according to the Union Health Ministry data updated on Friday. The death toll climbed to 4,51,814 with 379 fresh fatalities.

The daily rise in new coronavirus infections has been below 30,000 for 21 straight days and less than 50,000 daily new cases have been reported for 110 consecutive days now.

"The export policy of all diagnostic kits and reagents (including instruments /apparatus) ... is being made free with immediate effect," the directorate general of foreign trade (DGFT) said in a notification.

The DGFT is an arm of the commerce ministry which deals with export and import related norms.

The export restrictions on these products were imposed in June last year and August 16, 2021 on account of increasing COVID-19 cases. An exporter has to seek licence or permission from the government for exports of goods which are under a restricted category.

Diagnostic kits and reagents include RT-PCR kits and reagents, RNA extraction kits and reagents, synthetic fibre swabs, Proteinase K, magnetic stand, beads, and COVID-19 rapid antigen testing kits.

In a separate notification, the DGFT revised its earlier decision of October 4 with regard to export of syringes with or without needles.

It was earlier put under restricted category for export purposes, but now the curbs would be there for only certain denominations of syringes.

Further, in another notification, the directorate removed a ban on exports of melt blown fabric of any GSM, used in air filtration equipment, mask materials and liquid filtering materials..

"The melt blown fabric of any GSM has been made freely exportable with immediate effect," it said.

Read also: India resumes Covid-19 vaccine exports

Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Govt lifts export curbs on diagnostic kits, reagents

Similar News

USFDA warns pharma cos to remove misleading ads

Intas Pharma appoints Dr Ajay Kumar Handa as new Executive Vice President - RnD

Sun Pharma Halol facility gets OAI status from USFDA

Sanofi gets USFDA fast track designation for neovascular age-related macular degeneration gene therapy

Braille Labels, QR Code Voice Assistance on Drugs? CDSCO Seeks Stakeholder Comments

Tata Elxsi inaugrates Bayer Development Centre in Radiology at Pune

NPPA Notifies Ceiling Prices for IV Fluids in Advanced Packaging Formats, Details

AstraZeneca Gets SEC Approval to Conduct Phase IV Trial of Hyperkalemia Drug Sodium Zirconium Cyclosilicate